(Yeasen Biotechnology) was dissolved in DMSO, and water-soluble FYGL was dissolved in Na2CO3/NaHCO3 buffer. FITC (1 mg/mL) was added into the FYGL solution (1 mg/mL) to form FITC-FYGL, and the mixture
was incubated in the dark at 4 °C for 12 h. Extensive dialysis
of the mixture was performed using 1 L of PBS in the dark until the
unreacted FITC was removed. Finally, FITC-FYGL was
obtained. The ultraviolet (UV) spectra of FITC, FYGL, and FITC-FYGL are shown in
280 nm. It can be estimated that the ratio of FYGL and FITC in FITC-FYGL is 100:117 according to the
following equation:62 (link) where F and P represent FITC
and protein, and A denotes the absorbance. C2C12 myoblasts were seeded
at a density of 2 × 105 cells/well in six-well plates,
and fully differentiated myotubes were incubated with 100 μg/mL
FITC-FYGL for 4 h. DAPI (Beyotime, Shanghai, China)
and rhodamine phalloidin were used for nuclear and cytoskeleton staining,
respectively. The absorption of FITC-FYGL in C2C12
myotubes was observed under a laser confocal microscope (C2+; Nikon,
Tokyo, Japan).